163 related articles for article (PubMed ID: 37123046)
21. Tryptophan: Its Metabolism along the Kynurenine, Serotonin, and Indole Pathway in Malignant Melanoma.
Hubková B; Valko-Rokytovská M; Čižmárová B; Zábavníková M; Mareková M; Birková A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012419
[TBL] [Abstract][Full Text] [Related]
22. Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer.
Passarelli A; Pisano C; Cecere SC; Di Napoli M; Rossetti S; Tambaro R; Ventriglia J; Gherardi F; Iannacone E; Venanzio SS; Fiore F; Bartoletti M; Scognamiglio G; Califano D; Pignata S
Front Immunol; 2022; 13():953115. PubMed ID: 36119020
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma.
Guastella AR; Michelhaugh SK; Klinger NV; Kupsky WJ; Polin LA; Muzik O; Juhász C; Mittal S
Mol Imaging; 2016; 15():. PubMed ID: 27151136
[TBL] [Abstract][Full Text] [Related]
24. l-Tryptophan-Induced Vasodilation Is Enhanced in Preeclampsia: Studies on Its Uptake and Metabolism in the Human Placenta.
Broekhuizen M; Klein T; Hitzerd E; de Rijke YB; Schoenmakers S; Sedlmayr P; Danser AHJ; Merkus D; Reiss IKM
Hypertension; 2020 Jul; 76(1):184-194. PubMed ID: 32475317
[TBL] [Abstract][Full Text] [Related]
25. Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism.
Li Y; Hu N; Yang D; Oxenkrug G; Yang Q
FEBS J; 2017 Mar; 284(6):948-966. PubMed ID: 28118532
[TBL] [Abstract][Full Text] [Related]
26.
Wong A; Callahan J; Keyaerts M; Neyns B; Mangana J; Aberle S; Herschtal A; Fullerton S; Milne D; Iravani A; McArthur GA; Hicks RJ
Cancer Imaging; 2020 May; 20(1):36. PubMed ID: 32408884
[TBL] [Abstract][Full Text] [Related]
27. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer.
Ghafouri-Fard S; Taherian-Esfahani Z; Dashti S; Kholghi Oskooei V; Taheri M; Samsami M
Exp Mol Pathol; 2020 Jun; 114():104415. PubMed ID: 32165090
[TBL] [Abstract][Full Text] [Related]
28. Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.
Seban RD; Moya-Plana A; Antonios L; Yeh R; Marabelle A; Deutsch E; Schwartz LH; Gómez RGH; Saenger Y; Robert C; Ammari S; Dercle L
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2301-2312. PubMed ID: 32206839
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
[TBL] [Abstract][Full Text] [Related]
30. Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study.
van der Hiel B; Haanen JBAG; Stokkel MPM; Peeper DS; Jimenez CR; Beijnen JH; van de Wiel BA; Boellaard R; van den Eertwegh AJM;
BMC Cancer; 2017 Sep; 17(1):649. PubMed ID: 28915798
[TBL] [Abstract][Full Text] [Related]
31. Interim [
Sachpekidis C; Kopp-Schneider A; Pan L; Papamichail D; Haberkorn U; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1932-1943. PubMed ID: 33336264
[TBL] [Abstract][Full Text] [Related]
32. Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells.
Serbecic N; Lahdou I; Scheuerle A; Höftberger R; Aboul-Enein F
Mol Vis; 2009 Jul; 15():1312-24. PubMed ID: 19597571
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.
Zakharia Y; McWilliams RR; Rixe O; Drabick J; Shaheen MF; Grossmann KF; Kolhe R; Pacholczyk R; Sadek R; Tennant LL; Smith CM; Kennedy EP; Link CJ; Vahanian NN; Yu J; Shen SS; Brincks EL; Rossi GR; Munn D; Milhem M
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34117113
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of L- and D-5-[
Tang T; Gill HS; Ogasawara A; Tinianow JN; Vanderbilt AN; Williams SP; Hatzivassiliou G; White S; Sandoval W; DeMent K; Wong M; Marik J
Nucl Med Biol; 2017 Aug; 51():10-17. PubMed ID: 28511073
[TBL] [Abstract][Full Text] [Related]
35. Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors.
Batista CE; Juhász C; Muzik O; Kupsky WJ; Barger G; Chugani HT; Mittal S; Sood S; Chakraborty PK; Chugani DC
Mol Imaging Biol; 2009; 11(6):460-6. PubMed ID: 19434461
[TBL] [Abstract][Full Text] [Related]
36. Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.
Alkonyi B; Barger GR; Mittal S; Muzik O; Chugani DC; Bahl G; Robinette NL; Kupsky WJ; Chakraborty PK; Juhász C
J Nucl Med; 2012 Jul; 53(7):1058-64. PubMed ID: 22653792
[TBL] [Abstract][Full Text] [Related]
37. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
38. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
39. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients.
Hascitha J; Priya R; Jayavelu S; Dhandapani H; Selvaluxmy G; Sunder Singh S; Rajkumar T
Clin Biochem; 2016 Aug; 49(12):919-24. PubMed ID: 27106797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
